Michael Chancellor
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Chancellor
Earlier roles on record: Board Member at Lipella Pharmaceuticals Inc. (LIPO) until December 4, 2025. Lipella Pharmaceuticals Inc. reported in an 8-K filed October 9, 2025 that Michael Chancellor retired as member of the Company's Board of Directors, effective December 4, 2025. The proxy statement of Lipella Pharmaceuticals Inc. reports total compensation of $315,083 for Michael Chancellor in fiscal 2023, including a base salary of $195,833. Disclosed compensation is on record for 3 fiscal years.
“On October 3, 2025, Dr. Michael Chancellor notified Lipella Pharmaceuticals Inc. (the "Company") of his intention to retire from his positions as the Company's Chief Medical Officer and a member of the Company's Board of Directors, effective December 4, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2008-01-01–2025-12-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Medical Officer | $195,833 | $315,083 |
| 2022 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Medical Officer | $175,000 | $905,500 |
| 2021 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Medical Officer | $101,267 | $831,767 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.